Authors: Hossain, MM Margolis, DM

Citation: Mm. Hossain et Dm. Margolis, Inhibition of HIV replication by A77 1726, the active metabolite of leflunomide, in combination with pyrimidine nucleoside reverse transcriptase inhibitors, J ACQ IMM D, 28(2), 2001, pp. 199-201

Authors: Coull, JJ Turner, D Melby, T Betts, MR Lanier, R Margolis, DM

Citation: Jj. Coull et al., A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection, J ACQ IMM D, 26(5), 2001, pp. 423-434

Authors: Coull, JJ Romerio, F Sun, JM Volker, JL Galvin, KM Davie, JR Shi, Y Hansen, U Margolis, DM

Citation: Jj. Coull et al., The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1, J VIROLOGY, 74(15), 2000, pp. 6790-6799

Authors: Moriuchi, M Moriuchi, H Margolis, DM Fauci, AS

Citation: M. Moriuchi et al., USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry, J IMMUNOL, 162(10), 1999, pp. 5986-5992

Authors: Romerio, F Margolis, DM

Citation: F. Romerio et Dm. Margolis, In vitro techniques for studies of HIV-1 promoter activity, METH MOL M, 17, 1999, pp. 197-203